Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Virtual Clinical Trials Market, by Study Type
1.4.2 Global Virtual Clinical Trials Market, by Indication
1.4.3 Global Virtual Clinical Trials Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Nov) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
Chapter 4. Global Virtual Clinical Trials Market by Study Type
4.1 Global Interventional Market by Region
4.2 Global Observational Market by Region
4.3 Global Expanded Access Market by Region
Chapter 5. Global Virtual Clinical Trials Market by Indication
5.1 Global Oncology Market by Region
5.2 Global Cardiovascular Market by Region
5.3 Global Immunology Market by Region
5.4 Global Gastrointestinal Market by Region
5.5 Global Respiratory Market by Region
5.6 Global Endocrinology Market by Region
5.7 Global Ophthalmology Market by Region
5.8 Global Other Indications Market by Region
Chapter 6. Global Virtual Clinical Trials Market by Region
6.1 North America Virtual Clinical Trials Market
6.1.1 North America Virtual Clinical Trials Market by Study Type
6.1.1.1 North America Interventional Market by Country
6.1.1.2 North America Observational Market by Country
6.1.1.3 North America Expanded Access Market by Country
6.1.1.4 North America Virtual Clinical Trials Market by Indication
6.1.1.5 North America Oncology Market by Country
6.1.1.6 North America Cardiovascular Market by Country
6.1.1.7 North America Immunology Market by Country
6.1.1.8 North America Gastrointestinal Market by Country
6.1.1.9 North America Respiratory Market by Country
6.1.1.10 North America Endocrinology Market by Country
6.1.1.11 North America Ophthalmology Market by Country
6.1.1.12 North America Other Indications Market by Country
6.1.2 North America Virtual Clinical Trials Market by Country
6.1.2.1 US Virtual Clinical Trials Market
6.1.2.1.1 US Virtual Clinical Trials Market by Study Type
6.1.2.1.2 US Virtual Clinical Trials Market by Indication
6.1.2.2 Canada Virtual Clinical Trials Market
6.1.2.2.1 Canada Virtual Clinical Trials Market by Study Type
6.1.2.2.2 Canada Virtual Clinical Trials Market by Indication
6.1.2.3 Mexico Virtual Clinical Trials Market
6.1.2.3.1 Mexico Virtual Clinical Trials Market by Study Type
6.1.2.3.2 Mexico Virtual Clinical Trials Market by Indication
6.1.2.4 Rest of North America Virtual Clinical Trials Market
6.1.2.4.1 Rest of North America Virtual Clinical Trials Market by Study Type
6.1.2.4.2 Rest of North America Virtual Clinical Trials Market by Indication
6.2 Europe Virtual Clinical Trials Market
6.2.1 Europe Virtual Clinical Trials Market by Study Type
6.2.1.1 Europe Interventional Market by Country
6.2.1.2 Europe Observational Market by Country
6.2.1.3 Europe Expanded Access Market by Country
6.2.2 Europe Virtual Clinical Trials Market by Indication
6.2.2.1 Europe Oncology Market by Country
6.2.2.2 Europe Cardiovascular Market by Country
6.2.2.3 Europe Immunology Market by Country
6.2.2.4 Europe Gastrointestinal Market by Country
6.2.2.5 Europe Respiratory Market by Country
6.2.2.6 Europe Endocrinology Market by Country
6.2.2.7 Europe Ophthalmology Market by Country
6.2.2.8 Europe Other Indications Market by Country
6.2.3 Europe Virtual Clinical Trials Market by Country
6.2.3.1 Germany Virtual Clinical Trials Market
6.2.3.1.1 Germany Virtual Clinical Trials Market by Study Type
6.2.3.1.2 Germany Virtual Clinical Trials Market by Indication
6.2.3.2 UK Virtual Clinical Trials Market
6.2.3.2.1 UK Virtual Clinical Trials Market by Study Type
6.2.3.2.2 UK Virtual Clinical Trials Market by Indication
6.2.3.3 France Virtual Clinical Trials Market
6.2.3.3.1 France Virtual Clinical Trials Market by Study Type
6.2.3.3.2 France Virtual Clinical Trials Market by Indication
6.2.3.4 Russia Virtual Clinical Trials Market
6.2.3.4.1 Russia Virtual Clinical Trials Market by Study Type
6.2.3.4.2 Russia Virtual Clinical Trials Market by Indication
6.2.3.5 Spain Virtual Clinical Trials Market
6.2.3.5.1 Spain Virtual Clinical Trials Market by Study Type
6.2.3.5.2 Spain Virtual Clinical Trials Market by Indication
6.2.3.6 Italy Virtual Clinical Trials Market
6.2.3.6.1 Italy Virtual Clinical Trials Market by Study Type
6.2.3.6.2 Italy Virtual Clinical Trials Market by Indication
6.2.3.7 Rest of Europe Virtual Clinical Trials Market
6.2.3.7.1 Rest of Europe Virtual Clinical Trials Market by Study Type
6.2.3.7.2 Rest of Europe Virtual Clinical Trials Market by Indication
6.3 Asia Pacific Virtual Clinical Trials Market
6.3.1 Asia Pacific Virtual Clinical Trials Market by Study Type
6.3.1.1 Asia Pacific Interventional Market by Country
6.3.1.2 Asia Pacific Observational Market by Country
6.3.1.3 Asia Pacific Expanded Access Market by Country
6.3.2 Asia Pacific Virtual Clinical Trials Market by Indication
6.3.2.1 Asia Pacific Oncology Market by Country
6.3.2.2 Asia Pacific Cardiovascular Market by Country
6.3.2.3 Asia Pacific Immunology Market by Country
6.3.2.4 Asia Pacific Gastrointestinal Market by Country
6.3.2.5 Asia Pacific Respiratory Market by Country
6.3.2.6 Asia Pacific Endocrinology Market by Country
6.3.2.7 Asia Pacific Ophthalmology Market by Country
6.3.2.8 Asia Pacific Other Indications Market by Country
6.3.3 Asia Pacific Virtual Clinical Trials Market by Country
6.3.3.1 China Virtual Clinical Trials Market
6.3.3.1.1 China Virtual Clinical Trials Market by Study Type
6.3.3.1.2 China Virtual Clinical Trials Market by Indication
6.3.3.2 Japan Virtual Clinical Trials Market
6.3.3.2.1 Japan Virtual Clinical Trials Market by Study Type
6.3.3.2.2 Japan Virtual Clinical Trials Market by Indication
6.3.3.3 India Virtual Clinical Trials Market
6.3.3.3.1 India Virtual Clinical Trials Market by Study Type
6.3.3.3.2 India Virtual Clinical Trials Market by Indication
6.3.3.4 South Korea Virtual Clinical Trials Market
6.3.3.4.1 South Korea Virtual Clinical Trials Market by Study Type
6.3.3.4.2 South Korea Virtual Clinical Trials Market by Indication
6.3.3.5 Singapore Virtual Clinical Trials Market
6.3.3.5.1 Singapore Virtual Clinical Trials Market by Study Type
6.3.3.5.2 Singapore Virtual Clinical Trials Market by Indication
6.3.3.6 Malaysia Virtual Clinical Trials Market
6.3.3.6.1 Malaysia Virtual Clinical Trials Market by Study Type
6.3.3.6.2 Malaysia Virtual Clinical Trials Market by Indication
6.3.3.7 Rest of Asia Pacific Virtual Clinical Trials Market
6.3.3.7.1 Rest of Asia Pacific Virtual Clinical Trials Market by Study Type
6.3.3.7.2 Rest of Asia Pacific Virtual Clinical Trials Market by Indication
6.4 LAMEA Virtual Clinical Trials Market
6.4.1 LAMEA Virtual Clinical Trials Market by Study Type
6.4.1.1 LAMEA Interventional Market by Country
6.4.1.2 LAMEA Observational Market by Country
6.4.1.3 LAMEA Expanded Access Market by Country
6.4.2 LAMEA Virtual Clinical Trials Market by Indication
6.4.2.1 LAMEA Oncology Market by Country
6.4.2.2 LAMEA Cardiovascular Market by Country
6.4.2.3 LAMEA Immunology Market by Country
6.4.2.4 LAMEA Gastrointestinal Market by Country
6.4.2.5 LAMEA Respiratory Market by Country
6.4.2.6 LAMEA Endocrinology Market by Country
6.4.2.7 LAMEA Ophthalmology Market by Country
6.4.2.8 LAMEA Other Indications Market by Country
6.4.3 LAMEA Virtual Clinical Trials Market by Country
6.4.3.1 Brazil Virtual Clinical Trials Market
6.4.3.1.1 Brazil Virtual Clinical Trials Market by Study Type
6.4.3.1.2 Brazil Virtual Clinical Trials Market by Indication
6.4.3.2 Argentina Virtual Clinical Trials Market
6.4.3.2.1 Argentina Virtual Clinical Trials Market by Study Type
6.4.3.2.2 Argentina Virtual Clinical Trials Market by Indication
6.4.3.3 UAE Virtual Clinical Trials Market
6.4.3.3.1 UAE Virtual Clinical Trials Market by Study Type
6.4.3.3.2 UAE Virtual Clinical Trials Market by Indication
6.4.3.4 Saudi Arabia Virtual Clinical Trials Market
6.4.3.4.1 Saudi Arabia Virtual Clinical Trials Market by Study Type
6.4.3.4.2 Saudi Arabia Virtual Clinical Trials Market by Indication
6.4.3.5 South Africa Virtual Clinical Trials Market
6.4.3.5.1 South Africa Virtual Clinical Trials Market by Study Type
6.4.3.5.2 South Africa Virtual Clinical Trials Market by Indication
6.4.3.6 Nigeria Virtual Clinical Trials Market
6.4.3.6.1 Nigeria Virtual Clinical Trials Market by Study Type
6.4.3.6.2 Nigeria Virtual Clinical Trials Market by Indication
6.4.3.7 Rest of LAMEA Virtual Clinical Trials Market
6.4.3.7.1 Rest of LAMEA Virtual Clinical Trials Market by Study Type
6.4.3.7.2 Rest of LAMEA Virtual Clinical Trials Market by Indication
Chapter 7. Company Profiles
7.1 IQVIA Holdings, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 ICON PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.1 Recent strategies and developments:
7.2.1.1 Partnerships, Collaborations, and Agreements:
7.2.1.2 Product Launches and Product Expansions:
7.2.1.3 Acquisition and Mergers:
7.3 Laboratory Corporation of America Holdings (Covance, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Product Launches and Product Expansions:
7.3.4.2 Acquisition and Mergers:
7.4 Dassault Systemes SE (Medidata Solutions, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Oracle Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.6 Parexel International Corporation (Pamplona Capital Management)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Product Launches and Product Expansions:
7.6.2.3 Geographical Expansions:
7.7 PRA Health Sciences, Inc. (KKR & Co., Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Partnerships, Collaborations, and Agreements:
7.7.4.2 Product Launches and Product Expansions:
7.8 Medpace Holdings, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Recent strategies and developments:
7.8.3.1 Partnerships, Collaborations, and Agreements:
7.9 Medable, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Product Launches and Product Expansions:
7.10. Clinical Ink, Inc. (G.I. Partners)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 
